A randomized parallel-group controlled study for personalized postoperative pain management based on prediction of fentanyl requirements by genetic polymorphisms in patients undergoing orthognathic surgery

Not Applicable

Recruiting

• Conditions: Pain

• Registration Number: JPRN-UMIN000006805
• Lead Sponsor: Tokyo Metropolitan Institute of Medical Science

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2012-01-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

Not provided

Exclusion Criteria

Patients less than 15 years and more than 60 years or those with severe complications

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Predictability of Intravenous-Patient-controlled analgesia (IV-PCA) requirements for postoperative 24 h, patient's satisfaction, and/or composite endpoint including side effects

Secondary Outcome Measures

Name	Time	Method
Intravenous-Patient-controlled analgesia (IV-PCA) requirements for postoperative 24 h, visual analog scale, side effects (heart rate, blood pressure, SpO2, breathing, sedation score)